A new web-based tool utilizing AI can help pathologists detect prostate cancer faster, say Northeastern University researchers who developed the technology. Prostate cancer is the most common cancer ...
Prostate cancer is the second most common cancer in men, with over 288,000 new cases diagnosed each year. It is also one of the most curable cancers if detected early. A new imaging tool is helping ...
For men at the highest risk of prostate cancer as determined by a polygenic risk score, the percentage found to have clinically significant disease was higher than the percentage that would have been ...
When U.S. Sen. Bob Casey of Pennsylvania courageously shared his prostate cancer diagnosis and surgery earlier this year, he credited the support of his family and his exceptional medical care for his ...
Approximately 20% to 30% of men with prostate cancer experience disease recurrence within 5 years of therapeutic intervention. 1 A key challenge in managing these patients is a scarcity of accurate ...
In cases of clinical equipoise, the highest MMAI score quartile could guide selective treatment intensification among patients with high-risk nonmetastatic prostate cancer. An artificial ...
A common method of detecting prostate cancer may not be accurate enough as a reliable screening tool by itself, scientists have warned. The digital rectal exam (DRE) is widely used by medical ...
Scientists at the University of Cambridge, in collaboration with researchers at the Institute of Cancer Research, London, have developed a new computational algorithm to help predict a man's ...
Thanks to early detection and aggressive treatment for prostate cancer, 97 percent of all men diagnosed with the disease will survive at least 5 years and nearly 80 percent will survive at least a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results